Management of the ascending aorta in patients with bicuspid aortic valve disease
Related Experiment Video
Updated: Jul 4, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Michael P Vallely1, Christopher Semsarian, Paul G Bannon
1The Baird Institute, Sydney, Australia. michael.vallely@bigpond.com
Abstract:
Bicuspid aortic valve (BAV) disease is the most common form of congenital heart disease, affecting 1-2% of the population. Only 20% of patients will maintain normal valve function throughout their life and more than 30% of patients will develop serious morbidity. It is a highly heritable condition, with transmission likely to be autosomal dominant. Patients with BAV have a 10-fold risk of aortic dissection when compared to the normal population. Management of BAV associated aortopathy represents a significant clinical challenge.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Aortic Regurgitation IV: Nursing Management
Aortic Regurgitation I: Introduction
Aneurysm III: Interprofessional Care
Mitral Regurgitation III: Medical Management
